Line |
Label |
Object Class |
Period Type |
Balance |
Report ElementName |
1 |
00000001 - Document - Document and Entity Information |
Network |
* |
* |
http://info@tizianalifesciences.com/role/DocumentAndEntityInformation |
2 |
Implied Table |
Table |
* |
* |
implied:Table |
3 |
Document And Entity Information |
Abstract |
|
|
TLSA:DocumentAndEntityInformationAbstract |
4 |
Entity Registrant Name |
Concept (Text/String) |
For Period |
|
dei:EntityRegistrantName |
5 |
Entity Central Index Key |
Concept (CIK Number) |
For Period |
|
dei:EntityCentralIndexKey |
6 |
Trading Symbol |
Concept (Text/String) |
For Period |
|
dei:TradingSymbol |
7 |
Amendment Flag |
Concept (Yes/No) |
For Period |
|
dei:AmendmentFlag |
8 |
Current Fiscal Year End Date |
Concept (Month/Day) |
For Period |
|
dei:CurrentFiscalYearEndDate |
9 |
Document Type |
Concept (Submission Type) |
For Period |
|
dei:DocumentType |
10 |
Document Period End Date |
Concept (Date) |
For Period |
|
dei:DocumentPeriodEndDate |
11 |
Document Fiscal Period Focus |
Concept (Fiscal Period) |
For Period |
|
dei:DocumentFiscalPeriodFocus |
12 |
Document Fiscal Year Focus |
Concept (Year) |
For Period |
|
dei:DocumentFiscalYearFocus |
13 |
Entity Well-known Seasoned Issuer |
Concept (Yes/No) |
For Period |
|
dei:EntityWellKnownSeasonedIssuer |
14 |
Entity Voluntary Filers |
Concept (Yes/No) |
For Period |
|
dei:EntityVoluntaryFilers |
15 |
Entity Current Reporting Status |
Concept (Yes/No) |
For Period |
|
dei:EntityCurrentReportingStatus |
16 |
Entity Filer Category |
Concept (Filer Category) |
For Period |
|
dei:EntityFilerCategory |
17 |
Entity Emerging Growth Company |
Concept (Yes/No) |
For Period |
|
dei:EntityEmergingGrowthCompany |
18 |
Entity Ex Transition Period |
Concept (Yes/No) |
For Period |
|
dei:EntityExTransitionPeriod |
19 |
Entity Shell Company |
Concept (Yes/No) |
For Period |
|
dei:EntityShellCompany |
20 |
Entity Common Stock, Shares Outstanding |
Concept (Shares) |
As Of |
|
dei:EntityCommonStockSharesOutstanding |
21 |
00000002 - Statement - Consolidated Balance Sheets |
Network |
* |
* |
http://info@tizianalifesciences.com/role/BalanceSheets |
22 |
Implied Table |
Table |
* |
* |
implied:Table |
23 |
Statement of financial position [abstract] |
Abstract |
|
|
ifrs-full:StatementOfFinancialPositionAbstract |
24 |
ASSETS |
Abstract |
|
|
ifrs-full:AssetsAbstract |
25 |
Current assets: |
Abstract |
|
|
ifrs-full:CurrentAssetsAbstract |
26 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
27 |
Prepayments and other receivables |
Concept (Monetary) |
As Of |
Debit |
TLSA:PrepaymentsandOtherReceivablesCurrent |
28 |
Total current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentAssets |
29 |
Property and Equipment, net |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
30 |
Total non-current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentAssets |
31 |
Total assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Assets |
32 |
LIABILITIES AND SHAREHOLDERS' EQUITY |
Abstract |
|
|
ifrs-full:EquityAndLiabilitiesAbstract |
33 |
Liabilities: |
Abstract |
|
|
ifrs-full:LiabilitiesAbstract |
34 |
Current liabilities: |
Abstract |
|
|
ifrs-full:CurrentLiabilitiesAbstract |
35 |
Accounts payable and accrued expenses |
Concept (Monetary) |
As Of |
Credit |
TLSA:AccountsPayableAndAccruedExpensesCurrent |
36 |
Total current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentLiabilities |
37 |
Total liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Liabilities |
38 |
Shareholders' Equity: |
Abstract |
|
|
ifrs-full:EquityAbstract |
39 |
Called up share capital |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IssuedCapital |
40 |
Share premium |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:SharePremium |
41 |
Share based payment reserve - Options |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ReserveOfSharebasedPayments |
42 |
Share based payment reserve - warrants |
Concept (Monetary) |
As Of |
Credit |
TLSA:ShareBasedPaymentReserveWarrants |
43 |
Convertible loan note reserve |
Concept (Monetary) |
As Of |
Credit |
TLSA:ReserveofConvertibleLoanNote |
44 |
Merger relief reserve |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:MergerReserve |
45 |
Other reserve |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherReserves |
46 |
Translation reserve |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ReserveOfExchangeDifferencesOnTranslation |
47 |
Capital reduction reserve |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CapitalRedemptionReserve |
48 |
Retained earnings |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:RetainedEarnings |
49 |
Total shareholders' equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
50 |
Total liabilities and shareholders' equity |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:EquityAndLiabilities |
51 |
00000003 - Statement - Consolidated Statements of Operations and Comprehensive Loss |
Network |
* |
* |
http://info@tizianalifesciences.com/role/StatementsOfOperationsAndComprehensiveLoss |
52 |
Implied Table |
Table |
* |
* |
implied:Table |
53 |
Profit or loss [abstract] |
Abstract |
|
|
ifrs-full:IncomeStatementAbstract |
54 |
Revenue |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:Revenue |
55 |
Cost of revenue |
Concept (Monetary) |
For Period |
Debit |
TLSA:CostOfRevenues |
56 |
Gross Profit |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GrossProfit |
57 |
Operating expenses: |
Abstract |
|
|
TLSA:OperatingExpenseAbstract |
58 |
Research and Development |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ResearchAndDevelopmentExpense |
59 |
Operating Expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:GeneralAndAdministrativeExpense |
60 |
Total operating expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:OperatingExpense |
61 |
Loss from operations |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromOperatingActivities |
62 |
Other income/(expense): |
Abstract |
|
|
TLSA:OtherIncomeExpenseAbstract |
63 |
Finance Income/(expense) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:FinanceIncomeCost |
64 |
Loss from operations before income taxes |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossBeforeTax |
65 |
Income tax provision |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
66 |
Loss for the year |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
67 |
Other Comprehensive loss: |
Abstract |
|
|
ifrs-full:OtherComprehensiveIncomeAbstract |
68 |
Currency translation |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation |
69 |
Comprehensive loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ComprehensiveIncome |
70 |
Basic and diluted loss per share attributable to common shareholders |
Concept (Share) |
For Period |
|
ifrs-full:BasicAndDilutedEarningsLossPerShare |
71 |
00000004 - Statement - Consolidated Statements of Shareholders' Equity |
Network |
* |
* |
http://info@tizianalifesciences.com/role/StatementsOfShareholdersEquity |
72 |
Statement Table [Table] |
Table |
* |
* |
TLSA:IfrsStatementTable |
73 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
74 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
75 |
Issued Capital |
Member |
|
|
ifrs-full:IssuedCapitalMember |
76 |
Share Premium |
Member |
|
|
ifrs-full:SharePremiumMember |
77 |
Share Based Payment Reserve (Options) |
Member |
|
|
ifrs-full:ReserveOfSharebasedPaymentsMember |
78 |
Share Based Payment Reserve (warrants) |
Member |
|
|
TLSA:SharesToBeIssuedReserveMember |
79 |
Convertible Loan Note Reserve |
Member |
|
|
TLSA:ConvertibleLoanNoteReserveMember |
80 |
Merger Reserve |
Member |
|
|
ifrs-full:MergerReserveMember |
81 |
Other Reserves |
Member |
|
|
ifrs-full:OtherReservesMember |
82 |
Retained Earnings |
Member |
|
|
ifrs-full:RetainedEarningsMember |
83 |
Capital Redemption Reserve |
Member |
|
|
ifrs-full:CapitalRedemptionReserveMember |
84 |
Translation Reserve |
Member |
|
|
ifrs-full:ReserveOfExchangeDifferencesOnTranslationMember |
85 |
Capital Reduction Reserve |
Member |
|
|
TLSA:CapitalReductionReserveMember |
86 |
Statement Line Items [Line Items] |
LineItems |
|
|
TLSA:IfrsStatementLineItems |
87 |
Beginning Balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
88 |
Transactions with owners |
Abstract |
|
|
TLSA:TransactionsWithOwnersAbstract |
89 |
Issue of share capital |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IssueOfEquity |
90 |
Share based payment (options) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughExerciseOfOptions |
91 |
Share based payment (warrants) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity |
92 |
Convertible loan note - equity component |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IssueOfConvertibleInstruments |
93 |
Option forfeited in the year |
Concept (Monetary) |
For Period |
Credit |
TLSA:OptionForfeited |
94 |
Options cancelled in the year |
Concept (Monetary) |
For Period |
Credit |
TLSA:CancellationOfOptions |
95 |
Cancellation of deferred shares |
Concept (Monetary) |
For Period |
Credit |
TLSA:CancellationofDeferredShares |
96 |
Capital Reduction |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ReductionOfIssuedCapital |
97 |
Prior Year Adjustment |
Concept (Monetary) |
For Period |
Debit |
TLSA:PriorYearAdjustment |
98 |
Convertible loan note interest |
Concept (Monetary) |
For Period |
Credit |
TLSA:IncreaseDecreaseThroughConvertibleLoanNoteInterest |
99 |
Convertible Loan Note Conversion |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughConversionOfConvertibleInstruments |
100 |
Total transactions with owners |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughTransactionsWithOwners |
101 |
Comprehensive income |
Abstract |
|
|
ifrs-full:ComprehensiveIncomeAbstract |
102 |
Loss for the period |
Concept (Monetary) |
For Period |
Credit |
TLSA:ProfitLoss1 |
103 |
Translation |
Concept (Monetary) |
For Period |
Credit |
TLSA:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation1 |
104 |
Total comprehensive income |
Concept (Monetary) |
For Period |
Credit |
TLSA:ComprehensiveIncome1 |
105 |
Ending Balance |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
106 |
00000005 - Statement - Consolidated Statements of Cash Flows |
Network |
* |
* |
http://info@tizianalifesciences.com/role/StatementsOfCashFlows |
107 |
Implied Table |
Table |
* |
* |
implied:Table |
108 |
Statement of cash flows [abstract] |
Abstract |
|
|
ifrs-full:StatementOfCashFlowsAbstract |
109 |
CASH FLOWS FROM OPERATING ACTIVITIES: |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInOperatingActivitiesAbstract |
110 |
Loss from operations before income taxes |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossBeforeTax |
111 |
Adjustments to reconcile net loss to net cash used in operating activities: |
Abstract |
|
|
ifrs-full:AdjustmentsForReconcileProfitLossAbstract |
112 |
Convertible loan interest accrued |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForInterestExpense |
113 |
Convertible loan interest paid as equity |
Concept (Monetary) |
For Period |
Credit |
TLSA:ConvertibleLoanInterestPaidClassifiedAsOperatingActivities |
114 |
Shares issued in lieu of fees |
Concept (Monetary) |
For Period |
Debit |
TLSA:SharesIssuedInLieuOfFees |
115 |
Share based payment - options |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForSharebasedPayments |
116 |
Cancellation of options |
Concept (Monetary) |
For Period |
Credit |
TLSA:AdjustmentsForCancellationofOptions |
117 |
Share based payment - warrants |
Concept (Monetary) |
For Period |
Debit |
TLSA:AdjustmentsForSharebasedPaymentsWarrants |
118 |
Net (increase)/decrease in operating assets/other receivables |
Concept (Monetary) |
For Period |
Debit |
TLSA:AdjustmentsForDecreaseIncreaseInoperatingAssetsOtherReceivables |
119 |
Net increase/(decrease) in operating liabilities /other liabilities |
Concept (Monetary) |
For Period |
Debit |
TLSA:AdjustmentsForDecreaseIncreaseInoperatingLiabilitiesOtherLiabilities |
120 |
Depreciation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDepreciationExpense |
121 |
Loss on foreign exchange |
Concept (Monetary) |
For Period |
Debit |
TLSA:AdjustmentsForForeignExchangeLossesGains |
122 |
Lease adjustment |
Concept (Monetary) |
For Period |
Debit |
TLSA:AdjustmentsforLeaseAdjustment |
123 |
Cash inflow from taxation |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities |
124 |
Net cash used in operating activities |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperations |
125 |
CASH FLOWS FROM INVESTING ACTIVITIES |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInInvestingActivitiesAbstract |
126 |
PPE |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
127 |
Acquisition of other investments |
Concept (Monetary) |
For Period |
Credit |
TLSA:PaymentsForAcquisitionofOtherInvestments |
128 |
Net cash used in investing activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInInvestingActivities |
129 |
CASH FLOWS FROM FINANCING ACTIVITIES: |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInFinancingActivitiesAbstract |
130 |
Proceeds from issuance of ordinary shares |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssuingShares |
131 |
Proceeds from issuance of convertible loan notes |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromBorrowingsClassifiedAsFinancingActivities |
132 |
Proceeds from issuance of warrants |
Concept (Monetary) |
For Period |
Debit |
TLSA:ProceedsFromIssuanceOfWarrant |
133 |
Fundraising cost |
Concept (Monetary) |
For Period |
Debit |
TLSA:FundraisingCost |
134 |
Net cash provided by financing activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInFinancingActivities |
135 |
Net increase/(decrease) in cash and cash equivalents |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges |
136 |
Cash and cash equivalent, beginning of period |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
137 |
Exchange difference |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents |
138 |
Cash and cash equivalent, end of period |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
139 |
00000006 - Disclosure - General Information |
Network |
* |
* |
http://info@tizianalifesciences.com/role/GeneralInformation |
140 |
Implied Table |
Table |
* |
* |
implied:Table |
141 |
General Information |
Abstract |
|
|
TLSA:GeneralInformationAbstract |
142 |
GENERAL INFORMATION |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfGeneralInformationAboutFinancialStatementsAndOrganization |
143 |
00000007 - Disclosure - Accounting Policies |
Network |
* |
* |
http://info@tizianalifesciences.com/role/AccountingPolicies |
144 |
Implied Table |
Table |
* |
* |
implied:Table |
145 |
Accounting Policies |
Abstract |
|
|
TLSA:DisclosureOfAccountingPoliciesAbstract |
146 |
ACCOUNTING POLICIES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory |
147 |
00000008 - Disclosure - Critical Accounting Estimates and Judgements |
Network |
* |
* |
http://info@tizianalifesciences.com/role/CriticalAccountingEstimatesAndJudgements |
148 |
Implied Table |
Table |
* |
* |
implied:Table |
149 |
Critical Accounting Estimates And Judgements |
Abstract |
|
|
TLSA:CriticalAccountingEstimatesandJudgementsAbstract |
150 |
CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory |
151 |
00000009 - Disclosure - Operating Loss |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OperatingLoss |
152 |
Implied Table |
Table |
* |
* |
implied:Table |
153 |
Operating Loss |
Abstract |
|
|
TLSA:OperatingLossAbstract |
154 |
OPERATING LOSS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfProfitLossFromOperatingActivitiesExplanatory |
155 |
00000010 - Disclosure - Segmental Reporting |
Network |
* |
* |
http://info@tizianalifesciences.com/role/SegmentalReporting |
156 |
Implied Table |
Table |
* |
* |
implied:Table |
157 |
Segmental Reporting |
Abstract |
|
|
TLSA:SegmentalReportingAbstract |
158 |
SEGMENTAL REPORTING |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DescriptionOfSegmentReportingExplanatory |
159 |
00000011 - Disclosure - Employees |
Network |
* |
* |
http://info@tizianalifesciences.com/role/Employees |
160 |
Implied Table |
Table |
* |
* |
implied:Table |
161 |
Employees |
Abstract |
|
|
TLSA:EmployeesAbstract |
162 |
EMPLOYEES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfInformationAboutEmployeesExplanatory |
163 |
00000012 - Disclosure - Remuneration of Key Management Personnel |
Network |
* |
* |
http://info@tizianalifesciences.com/role/RemunerationOfKeyManagementPersonnel |
164 |
Implied Table |
Table |
* |
* |
implied:Table |
165 |
Remuneration Of Key Management Personnel |
Abstract |
|
|
TLSA:RemunerationOfKeyManagementPersonnelAbstract |
166 |
REMUNERATION OF KEY MANAGEMENT PERSONNEL |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfRemunerationOfKeyManagementPersonnelTextBlock |
167 |
00000013 - Disclosure - Finance Costs |
Network |
* |
* |
http://info@tizianalifesciences.com/role/FinanceCosts |
168 |
Implied Table |
Table |
* |
* |
implied:Table |
169 |
Finance Costs [Abstract] |
Abstract |
|
|
TLSA:DisclosureOfFinanceCostAbstract |
170 |
FINANCE COSTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinanceCostExplanatory |
171 |
00000014 - Disclosure - Taxation |
Network |
* |
* |
http://info@tizianalifesciences.com/role/Taxation |
172 |
Implied Table |
Table |
* |
* |
implied:Table |
173 |
Taxation [Abstract] |
Abstract |
|
|
TLSA:DisclosureOfTaxationAbstract |
174 |
TAXATION |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIncomeTaxExplanatory |
175 |
00000015 - Disclosure - Loss Per Share |
Network |
* |
* |
http://info@tizianalifesciences.com/role/LossPerShare |
176 |
Implied Table |
Table |
* |
* |
implied:Table |
177 |
Loss Per Share |
Abstract |
|
|
TLSA:DisclosureOfLossPerShareAbstract |
178 |
LOSS PER SHARE |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEarningsPerShareExplanatory |
179 |
00000016 - Disclosure - Property, IT and Equipment |
Network |
* |
* |
http://info@tizianalifesciences.com/role/PropertyItAndEquipment |
180 |
Implied Table |
Table |
* |
* |
implied:Table |
181 |
Property It And Equipment |
Abstract |
|
|
TLSA:PropertyItAndEquipmentAbstract |
182 |
PROPERTY, IT AND EQUIPMENT |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory |
183 |
00000017 - Disclosure - Other Receivables |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OtherReceivables |
184 |
Implied Table |
Table |
* |
* |
implied:Table |
185 |
Other Receivables |
Abstract |
|
|
TLSA:OtherReceivablesAbstract |
186 |
OTHER RECEIVABLES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory |
187 |
00000018 - Disclosure - Other Assets |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OtherAssets |
188 |
Implied Table |
Table |
* |
* |
implied:Table |
189 |
Other Assets |
Abstract |
|
|
TLSA:OtherAssetsAbstract |
190 |
OTHER ASSETS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfOtherAssetsExplanatory |
191 |
00000019 - Disclosure - Investments in Subsidiaries |
Network |
* |
* |
http://info@tizianalifesciences.com/role/InvestmentsInSubsidiaries |
192 |
Implied Table |
Table |
* |
* |
implied:Table |
193 |
Disclosure of subsidiaries [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesAbstract |
194 |
INVESTMENTS IN SUBSIDIARIES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesExplanatory |
195 |
00000020 - Disclosure - Share Capital |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ShareCapital |
196 |
Implied Table |
Table |
* |
* |
implied:Table |
197 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
198 |
SHARE CAPITAL |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory |
199 |
00000021 - Disclosure - Share Based Payments |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ShareBasedPayments |
200 |
Implied Table |
Table |
* |
* |
implied:Table |
201 |
Share Based Payments |
Abstract |
|
|
TLSA:DisclosureofShareBasedPaymentsAlbstract |
202 |
SHARE BASED PAYMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory |
203 |
00000022 - Disclosure - Convertible Loan Notes |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ConvertibleLoanNotes |
204 |
Implied Table |
Table |
* |
* |
implied:Table |
205 |
Convertible Loan Notes |
Abstract |
|
|
TLSA:ConvertibleLoanNotesAbstract |
206 |
CONVERTIBLE LOAN NOTES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfBorrowingsExplanatory |
207 |
00000023 - Disclosure - Reserves |
Network |
* |
* |
http://info@tizianalifesciences.com/role/Reserves |
208 |
Implied Table |
Table |
* |
* |
implied:Table |
209 |
Notes to Financial Statements |
Abstract |
|
|
TLSA:NotesToFinancialStatementsAbstract |
210 |
RESERVES |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfReservesExplanatoryTextBlock |
211 |
00000024 - Disclosure - Financial Instruments |
Network |
* |
* |
http://info@tizianalifesciences.com/role/FinancialInstruments |
212 |
Implied Table |
Table |
* |
* |
implied:Table |
213 |
Financial Instruments |
Abstract |
|
|
TLSA:FinancialInstrumentsAbstract |
214 |
FINANCIAL INSTRUMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinancialInstrumentsExplanatory |
215 |
00000025 - Disclosure - Capital Risk Management |
Network |
* |
* |
http://info@tizianalifesciences.com/role/CapitalRiskManagement |
216 |
Implied Table |
Table |
* |
* |
implied:Table |
217 |
Capital Risk Management |
Abstract |
|
|
TLSA:CapitalRiskManagementAbstract |
218 |
CAPITAL RISK MANAGEMENT |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinancialRiskManagementExplanatory |
219 |
00000026 - Disclosure - Trade and Other Payables |
Network |
* |
* |
http://info@tizianalifesciences.com/role/TradeAndOtherPayables |
220 |
Implied Table |
Table |
* |
* |
implied:Table |
221 |
Trade and other payables [abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherPayablesAbstract |
222 |
TRADE AND OTHER PAYABLES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTradeAndOtherPayablesExplanatory |
223 |
00000027 - Disclosure - Related Party Transactions |
Network |
* |
* |
http://info@tizianalifesciences.com/role/RelatedPartyTransactions |
224 |
Implied Table |
Table |
* |
* |
implied:Table |
225 |
Related party transactions [abstract] |
Abstract |
|
|
ifrs-full:RelatedPartyTransactionsAbstract |
226 |
RELATED PARTY TRANSACTIONS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfRelatedPartyExplanatory |
227 |
00000028 - Disclosure - Operating Leases |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OperatingLeases |
228 |
Implied Table |
Table |
* |
* |
implied:Table |
229 |
Operating Leases |
Abstract |
|
|
TLSA:OperatingLeasesAbstract |
230 |
OPERATING LEASES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfLeasesExplanatory |
231 |
00000029 - Disclosure - Post Balance Sheet Events - Post 31 December 2018 |
Network |
* |
* |
http://info@tizianalifesciences.com/role/PostBalanceSheetEvents-Post31December2018 |
232 |
Implied Table |
Table |
* |
* |
implied:Table |
233 |
Post Balance Sheet Events - Post 31 December 2018 |
Abstract |
|
|
TLSA:PostBalanceSheetEventsAbstract |
234 |
POST BALANCE SHEET EVENTS - POST 31 DECEMBER 2018 |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory |
235 |
00000030 - Disclosure - Financial Commitments |
Network |
* |
* |
http://info@tizianalifesciences.com/role/FinancialCommitments |
236 |
Implied Table |
Table |
* |
* |
implied:Table |
237 |
Financial Commitments |
Abstract |
|
|
TLSA:FinancialCommitmentsAbstract |
238 |
FINANCIAL COMMITMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCommitmentsExplanatory |
239 |
00000031 - Disclosure - Accounting Policies (Policies) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/AccountingPoliciesPolicies |
240 |
Implied Table |
Table |
* |
* |
implied:Table |
241 |
Accounting Policies |
Abstract |
|
|
TLSA:DisclosureOfAccountingPoliciesAbstract |
242 |
Basis of preparation |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DescriptionOfAccountingPolicyForBasisofPreparation |
243 |
Going Concern |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DescriptionOfAccountingPolicyForGoingConcern |
244 |
Basis of consolidation |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DescriptionOfAccountingPolicyForBasisofConsolidation |
245 |
Business combination |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory |
246 |
Segment reporting |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForSegmentReportingExplanatory |
247 |
Taxation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForTaxesOtherThanIncomeTaxExplanatory |
248 |
Foreign currency translation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory |
249 |
License fees |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DescriptionOfAccountingPolicyForLicenseFees |
250 |
Research and development |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory |
251 |
Financial instruments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory |
252 |
Share capital |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory |
253 |
Property, IT and equipment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory |
254 |
Impairment |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfAssetsExplanatory |
255 |
Operating leases |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory |
256 |
Share based payments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory |
257 |
Convertible loan notes |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForBorrowingsExplanatory |
258 |
00000032 - Disclosure - Accounting Policies (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/AccountingPoliciesTables |
259 |
Implied Table |
Table |
* |
* |
implied:Table |
260 |
Accounting Policies |
Abstract |
|
|
TLSA:DisclosureOfAccountingPoliciesAbstract |
261 |
Schedule of the revisions |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutRevisions |
262 |
Schedule of estimated useful lives for the current period and the comparative period |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutEstimatedUsefulLives |
263 |
00000033 - Disclosure - Operating Loss (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OperatingLossTables |
264 |
Implied Table |
Table |
* |
* |
implied:Table |
265 |
Operating Loss |
Abstract |
|
|
TLSA:OperatingLossAbstract |
266 |
Schedule of operating loss |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutOperatingLoss |
267 |
00000034 - Disclosure - Employees (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/EmployeesTables |
268 |
Implied Table |
Table |
* |
* |
implied:Table |
269 |
Employees |
Abstract |
|
|
TLSA:EmployeesAbstract |
270 |
Schedule of employees |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutEmployeesExplanatory |
271 |
00000035 - Disclosure - Remuneration of Key Management Personnel (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/RemunerationOfKeyManagementPersonnelTables |
272 |
Implied Table |
Table |
* |
* |
implied:Table |
273 |
Remuneration Of Key Management Personnel |
Abstract |
|
|
TLSA:RemunerationOfKeyManagementPersonnelAbstract |
274 |
Schedule of remuneration of key management personnel |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutRemunerationOfKeyManagementPersonnelTextBlock |
275 |
Schedule of share options were granted to directors |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfShareOptionsWereGrantedToDirectorsTextBlock |
276 |
00000036 - Disclosure - Finance Costs (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/FinanceCostsTables |
277 |
Implied Table |
Table |
* |
* |
implied:Table |
278 |
Finance Costs [Abstract] |
Abstract |
|
|
TLSA:DisclosureOfFinanceCostAbstract |
279 |
Schedule of finance costs |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureDetailedInformationAboutOfFinanceCostTableTextBlock |
280 |
00000037 - Disclosure - Taxation (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/TaxationTables |
281 |
Implied Table |
Table |
* |
* |
implied:Table |
282 |
Taxation [Abstract] |
Abstract |
|
|
TLSA:DisclosureOfTaxationAbstract |
283 |
Schedule of taxation |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutIncomeTaxExpenseBenefitTableTextBlock |
284 |
00000038 - Disclosure - Loss Per Share (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/LossPerShareTables |
285 |
Implied Table |
Table |
* |
* |
implied:Table |
286 |
Loss Per Share |
Abstract |
|
|
TLSA:DisclosureOfLossPerShareAbstract |
287 |
Schedule of basic loss per share |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutOfEarningsPerShareTableTextBlock |
288 |
00000039 - Disclosure - Property, IT and Equipment (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/PropertyItAndEquipmentTables |
289 |
Implied Table |
Table |
* |
* |
implied:Table |
290 |
Property It And Equipment |
Abstract |
|
|
TLSA:PropertyItAndEquipmentAbstract |
291 |
Schedule of property, IT and equipment |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutPropertyItAndEquipmentTableTextBlock |
292 |
00000040 - Disclosure - Other Receivables (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OtherReceivablesTables |
293 |
Implied Table |
Table |
* |
* |
implied:Table |
294 |
Other Receivables |
Abstract |
|
|
TLSA:OtherReceivablesAbstract |
295 |
Schedule of other receivables |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutOtherReceivablesTableTextBlock |
296 |
00000041 - Disclosure - Investments in Subsidiaries (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/InvestmentsInSubsidiariesTables |
297 |
Implied Table |
Table |
* |
* |
implied:Table |
298 |
Disclosure of subsidiaries [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfSignificantInvestmentsInSubsidiariesAbstract |
299 |
Schedule of interest in subsidiary undertakings |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureofDetailedInformationAboutSignificantInvestmentsInSubsidiariesExplanatory |
300 |
00000042 - Disclosure - Share Capital (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ShareCapitalTables |
301 |
Implied Table |
Table |
* |
* |
implied:Table |
302 |
Disclosure of classes of share capital [abstract] |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
303 |
Schedule of share capital |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutShareCapitalExplanatory |
304 |
00000043 - Disclosure - Share Based Payments (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ShareBasedPaymentsTables |
305 |
Implied Table |
Table |
* |
* |
implied:Table |
306 |
Share Based Payments |
Abstract |
|
|
TLSA:DisclosureofShareBasedPaymentsAlbstract |
307 |
Schedule of share-based payment arrangements |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutShareBasedPaymentArrangements |
308 |
Schedule of share options outstanding |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutShareOptionsOutstanding |
309 |
Schedule of estimated a forfeiture rate of zero |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:DisclosureOfDetailedInformationAboutforfeitureRate |
310 |
00000044 - Disclosure - Convertible Loan Notes (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ConvertibleLoanNotesTables |
311 |
Implied Table |
Table |
* |
* |
implied:Table |
312 |
Convertible Loan Notes |
Abstract |
|
|
TLSA:ConvertibleLoanNotesAbstract |
313 |
Schedule of planwise convertible loan note |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDetailedInformationAboutBorrowingsExplanatory |
314 |
00000045 - Disclosure - Financial Instruments (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/FinancialInstrumentsTables |
315 |
Implied Table |
Table |
* |
* |
implied:Table |
316 |
Financial Instruments |
Abstract |
|
|
TLSA:FinancialInstrumentsAbstract |
317 |
Schedule of financial liabilities based on contractual undiscounted payments |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:ScheduleOfFinancialLiabilitiesBasedOnContractualUndiscountedPaymentsTableTextBlock |
318 |
00000046 - Disclosure - Trade and Other Payables (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/TradeAndOtherPayablesTables |
319 |
Implied Table |
Table |
* |
* |
implied:Table |
320 |
Trade and other payables [abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherPayablesAbstract |
321 |
Schedule of trade and other payables |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:ScheduleOfTradeAndOtherPayablesTableTextBlock |
322 |
00000047 - Disclosure - Operating Leases (Tables) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OperatingLeasesTables |
323 |
Implied Table |
Table |
* |
* |
implied:Table |
324 |
Operating Leases |
Abstract |
|
|
TLSA:OperatingLeasesAbstract |
325 |
Schedule of future minimum rentals payable under non-cancellable operating leases |
Concept (Text Block (HTML)) |
For Period |
|
TLSA:ScheduleOfFutureMinimumRentalsPayableUnderNoncancellableOperatingLeases |
326 |
00000048 - Disclosure - Accounting Policies (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/AccountingPoliciesDetails |
327 |
IfrsDisclosureOfAccountingPoliciesTable [Table] |
Table |
* |
* |
TLSA:IfrsDisclosureOfAccountingPoliciesTable |
328 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
329 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
330 |
IT and equipment [Member] |
Member |
|
|
ifrs-full:CommunicationAndNetworkEquipmentMember |
331 |
Fixtures and fittings [Member] |
Member |
|
|
ifrs-full:FixturesAndFittingsMember |
332 |
IfrsDisclosureOfAccountingPoliciesLineItems [Line Items] |
LineItems |
|
|
TLSA:IfrsDisclosureOfAccountingPoliciesLineItems |
333 |
Estimated useful lives |
Concept (xbrli:durationItemType) |
For Period |
|
TLSA:EstimatedUsefulLives |
334 |
00000049 - Disclosure - Accounting Policies (Details Textual) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/AccountingPoliciesDetailsTextual |
335 |
Implied Table |
Table |
* |
* |
implied:Table |
336 |
Accounting Policies |
Abstract |
|
|
TLSA:DisclosureOfAccountingPoliciesAbstract |
337 |
Percentage of shareholders |
Concept (Percent) |
For Period |
|
ifrs-full:ProportionOfOwnershipInterestInSubsidiary |
338 |
Issue of ordinary share capital |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
339 |
00000050 - Disclosure - Operating Loss (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OperatingLossDetails |
340 |
Implied Table |
Table |
* |
* |
implied:Table |
341 |
Operating Loss |
Abstract |
|
|
TLSA:OperatingLossAbstract |
342 |
License fee |
Concept (Monetary) |
For Period |
Debit |
TLSA:Licensefee |
343 |
Depreciation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DepreciationExpense |
344 |
Foreign exchange (gain)/losses |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss |
345 |
Operating Loss |
Concept (Monetary) |
For Period |
Debit |
TLSA:OperatingLoss |
346 |
00000051 - Disclosure - Employees (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/EmployeesDetails |
347 |
Implied Table |
Table |
* |
* |
implied:Table |
348 |
Employees |
Abstract |
|
|
TLSA:EmployeesAbstract |
349 |
Staff costs comprised: |
Abstract |
|
|
TLSA:StaffCostsAbstract |
350 |
Directors' salaries |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:DirectorsRemunerationExpense |
351 |
Wages and salaries |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:WagesAndSalaries |
352 |
Social security costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SocialSecurityContributions |
353 |
Share based payment charge |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees |
354 |
Employees, total |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:EmployeeBenefitsExpense |
355 |
The average monthly number of employees, including directors, employed by the group during the year was: |
Abstract |
|
|
ifrs-full:NumberAndAverageNumberOfEmployeesAbstract |
356 |
Research and Development |
Concept (Monetary) |
For Period |
Debit |
TLSA:ResearchAndDevelopment |
357 |
Corporate and administration |
Concept (Monetary) |
For Period |
Debit |
TLSA:CorporateAndAdministration |
358 |
Average monthly number of employees, including directors, employed by the group |
Concept (Monetary) |
For Period |
Debit |
TLSA:AverageMonthlyNumberOfEmployeesIncludingDirectorsEmployedByGroup |
359 |
00000052 - Disclosure - Remuneration of Key Management Personnel (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/RemunerationOfKeyManagementPersonnelDetails |
360 |
RemunerationOfKeyManagementPersonnelTable [Table] |
Table |
* |
* |
TLSA:RemunerationOfKeyManagementPersonnelTable |
361 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
362 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
363 |
W Simon [Member] |
Member |
|
|
TLSA:WSimonMember |
364 |
G. Cerrone [Member] |
Member |
|
|
TLSA:GCerroneMember |
365 |
R. Dalla-Favera [Member] |
Member |
|
|
TLSA:RDallaFaveraMember |
366 |
K. Shailubhai [Member] |
Member |
|
|
TLSA:KShailubhaiMember |
367 |
RemunerationOfKeyManagementPersonnelLineItems [Line Items] |
LineItems |
|
|
TLSA:RemunerationOfKeyManagementPersonnelLineItems |
368 |
Schedule of remuneration of key management personnel [Abstract] |
Abstract |
|
|
TLSA:ScheduleOfRemunerationOfKeyManagementPersonnelAbstract |
369 |
Directors fees |
Concept (Monetary) |
For Period |
Debit |
TLSA:DirectorsFees |
370 |
Salary |
Concept (Monetary) |
For Period |
Debit |
TLSA:Salary |
371 |
00000053 - Disclosure - Remuneration of Key Management Personnel (Details 1) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/RemunerationOfKeyManagementPersonnelDetails1 |
372 |
RemunerationOfKeyManagementPersonnelTable [Table] |
Table |
* |
* |
TLSA:RemunerationOfKeyManagementPersonnelTable |
373 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
374 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
375 |
G. Cerrone [Member] |
Member |
|
|
TLSA:GCerroneMember |
376 |
K. Shailubhai [Member] |
Member |
|
|
TLSA:KShailubhaiMember |
377 |
L. Zanbeletti [Member] |
Member |
|
|
TLSA:ZanbelettiMember |
378 |
RemunerationOfKeyManagementPersonnelLineItems [Line Items] |
LineItems |
|
|
TLSA:RemunerationOfKeyManagementPersonnelLineItems |
379 |
Schedule of share options were granted to directors [Abstract] |
Abstract |
|
|
TLSA:ScheduleOfShareOptionsWereGrantedToDirectorsAbstract |
380 |
Number of share options |
Concept (Shares) |
For Period |
|
TLSA:NumberOfShareOptionsWereGrantedToDirectors |
381 |
00000054 - Disclosure - Remuneration of Key Management Personnel (Details Textual) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/RemunerationOfKeyManagementPersonnelDetailsTextual |
382 |
RemunerationOfKeyManagementPersonnelTable [Table] |
Table |
* |
* |
TLSA:RemunerationOfKeyManagementPersonnelTable |
383 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
384 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
385 |
Directors or Employees [Member] |
Member |
|
|
ifrs-full:KeyManagementPersonnelOfEntityOrParentMember |
386 |
RemunerationOfKeyManagementPersonnelLineItems [Line Items] |
LineItems |
|
|
TLSA:RemunerationOfKeyManagementPersonnelLineItems |
387 |
Remuneration of Key Management Personnel (Textual) |
Abstract |
|
|
TLSA:RemunerationOfKeyManagementPersonnelTextualAbstract |
388 |
Payments to a defined contribution pension schemes on behalf of directors or employees |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans |
389 |
00000055 - Disclosure - Finance Costs (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/FinanceCostsDetails |
390 |
Implied Table |
Table |
* |
* |
implied:Table |
391 |
Finance Costs [Abstract] |
Abstract |
|
|
TLSA:DisclosureOfFinanceCostAbstract |
392 |
Group |
Abstract |
|
|
TLSA:GroupAbstract |
393 |
Finance charge accrued on convertible loan notes (recognized as debt) |
Concept (Monetary) |
For Period |
Debit |
TLSA:FinanceChargeAccruedOnConvertibleLoanNotes |
394 |
Total finance costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
395 |
00000056 - Disclosure - Taxation (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/TaxationDetails |
396 |
Implied Table |
Table |
* |
* |
implied:Table |
397 |
Taxation [Abstract] |
Abstract |
|
|
TLSA:DisclosureOfTaxationAbstract |
398 |
Group |
Abstract |
|
|
TLSA:GroupAbstract |
399 |
Current year tax (credit) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CurrentTaxExpenseIncome |
400 |
Adjustments due to prior periods |
Concept (Monetary) |
For Period |
Debit |
TLSA:AdjustmentsDueToPriorPeriods |
401 |
Total tax (credit) for the period |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
402 |
The tax charge for the year is different from the standard rate of corporation tax in the United Kingdom of 21.49%. The difference can be reconciled as follows: |
Abstract |
|
|
TLSA:TaxChargeForYearIsDifferentFromStandardRateOfCorporationTaxAbstract |
403 |
Loss before taxation |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossBeforeTax |
404 |
Loss charged at standard rate of corporation tax 19 % (2017: 19.25%; 2016: 20%) |
Concept (Monetary) |
For Period |
Debit |
TLSA:IncomeTaxReconciliationLossChargedAtStandardRateOfCorporationTax |
405 |
Other timing differences |
Concept (Monetary) |
For Period |
Debit |
TLSA:IncomeTaxReconciliationOtherTimingDifferences |
406 |
Expenses not deductible for taxation |
Concept (Monetary) |
For Period |
Debit |
TLSA:IncomeTaxReconciliationExpensesNotDeductibleForTaxation |
407 |
Adjustments due to prior periods |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForCurrentTaxOfPriorPeriod |
408 |
Research and development claim |
Concept (Monetary) |
For Period |
Debit |
TLSA:IncomeTaxReconciliationResearchAndDevelopmentClaim |
409 |
Other timing differences |
Concept (Monetary) |
For Period |
Credit |
TLSA:IncomeTaxReconciliationTaxesOtherTimingDifferences |
410 |
Income tax expense (benefit) |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncomeTaxExpenseContinuingOperations |
411 |
00000058 - Disclosure - Loss Per Share (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/LossPerShareDetails |
412 |
Implied Table |
Table |
* |
* |
implied:Table |
413 |
Loss Per Share |
Abstract |
|
|
TLSA:DisclosureOfLossPerShareAbstract |
414 |
(Loss) attributable to equity holders of the company ($000) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity |
415 |
Weighted average number of ordinary shares in issue |
Concept (Shares) |
For Period |
|
ifrs-full:WeightedAverageShares |
416 |
Basic loss per share (cents per share) |
Concept (Share) |
For Period |
|
ifrs-full:BasicEarningsLossPerShare |
417 |
00000059 - Disclosure - Property, IT and Equipment (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/PropertyItAndEquipmentDetails |
418 |
IfrsPropertyItAndEquipmentTable [Table] |
Table |
* |
* |
TLSA:IfrsPropertyItAndEquipmentTable |
419 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
420 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
421 |
Fixtures and fittings [Member] |
Member |
|
|
ifrs-full:FixturesAndFittingsMember |
422 |
IT equipment [Member] |
Member |
|
|
ifrs-full:ComputerEquipmentMember |
423 |
IfrsPropertyItAndEquipmentLineItems [Line Items] |
LineItems |
|
|
TLSA:IfrsPropertyItAndEquipmentLineItems |
424 |
Cost |
Abstract |
|
|
TLSA:PropertyPlantEquipmentCostAbstract |
425 |
Beginning |
Concept (Monetary) |
As Of |
Debit |
TLSA:PropertyPlantEquipmentCost |
426 |
Additions |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment |
427 |
Disposals |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:DisposalsPropertyPlantAndEquipment |
428 |
Ending |
Concept (Monetary) |
As Of |
Debit |
TLSA:PropertyPlantEquipmentCost |
429 |
Depreciation |
Abstract |
|
|
TLSA:PropertyPlantEquipmentDepreciationAbstract |
430 |
Beginning |
Concept (Monetary) |
As Of |
Credit |
TLSA:DepreciationImpairmentPropertyPlantEquipment |
431 |
Charge in year |
Concept (Monetary) |
For Period |
|
ifrs-full:DepreciationPropertyPlantAndEquipment |
432 |
Ending |
Concept (Monetary) |
As Of |
Credit |
TLSA:DepreciationImpairmentPropertyPlantEquipment |
433 |
Net Book Value |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
434 |
00000060 - Disclosure - Other Receivables (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OtherReceivablesDetails |
435 |
Implied Table |
Table |
* |
* |
implied:Table |
436 |
Other Receivables |
Abstract |
|
|
TLSA:OtherReceivablesAbstract |
437 |
Group |
Abstract |
|
|
ifrs-full:TradeAndOtherReceivablesAbstract |
438 |
Other receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherReceivables |
439 |
Taxation receivable |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:ReceivablesFromTaxesOtherThanIncomeTax |
440 |
Related party receivable |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:AmountsReceivableRelatedPartyTransactions |
441 |
Prepayments |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Prepayments |
442 |
Other current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:OtherCurrentAssets |
443 |
Total |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:TradeAndOtherReceivables |
444 |
00000062 - Disclosure - Investments in Subsidiaries (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/InvestmentsInSubsidiariesDetails |
445 |
IfrsDisclosureOfSignificantInvestmentsInSubsidiariesTable [Table] |
Table |
* |
* |
TLSA:IfrsDisclosureOfSignificantInvestmentsInSubsidiariesTable |
446 |
Subsidiaries [axis] |
Axis |
|
|
ifrs-full:SignificantInvestmentsInSubsidiariesAxis |
447 |
Entity's total for subsidiaries [member] |
Member |
|
|
ifrs-full:EntitysTotalForSubsidiariesMember |
448 |
Tiziana Pharma Limited [Member] |
Member |
|
|
TLSA:TizianaPharmaLimitedMember |
449 |
Tiziana Therapeutics Inc [Member] |
Member |
|
|
TLSA:TizianaTherapeuticsIncMember |
450 |
Longevia Genomics SRL [Member] |
Member |
|
|
TLSA:LongeviaGenomicsSRLMember |
451 |
IfrsDisclosureOfSignificantInvestmentsInSubsidiariesLineItems [Line Items] |
LineItems |
|
|
TLSA:IfrsDisclosureOfSignificantInvestmentsInSubsidiariesLineItems |
452 |
Name |
Concept (Text/String) |
For Period |
|
ifrs-full:NameOfSubsidiary |
453 |
Principal activity |
Concept (Text/String) |
For Period |
|
TLSA:PrincipalActivityInSubsidiaries |
454 |
Registered Address |
Concept (Text/String) |
For Period |
|
ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary |
455 |
Percentage shareholding |
Concept (Percent) |
For Period |
|
TLSA:PercentageofInvestmentsInSubsidiaries |
456 |
Country of incorporation |
Concept (Text/String) |
For Period |
|
ifrs-full:CountryOfIncorporation |
457 |
00000065 - Disclosure - Share Based Payments (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ShareBasedPaymentsDetails |
458 |
Implied Table |
Table |
* |
* |
implied:Table |
459 |
Share Based Payments |
Abstract |
|
|
TLSA:DisclosureofShareBasedPaymentsAlbstract |
460 |
Weighted Average exercise price (cents) |
Abstract |
|
|
TLSA:WeightedAverageexercisepriceAbstract |
461 |
Outstanding at 1 January |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
462 |
Granted |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
463 |
Forfeited |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement |
464 |
Outstanding at 31 December |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
465 |
Exercisable at 31 December |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement |
466 |
Options ('000) |
Abstract |
|
|
TLSA:OptionsAbstract |
467 |
Outstanding at 1 January |
Concept (Shares) |
As Of |
|
TLSA:NumberOfShareOptionsOutstanding |
468 |
Granted |
Concept (Shares) |
For Period |
|
TLSA:NumberOfShareOptionsGranted |
469 |
Forfeited |
Concept (Shares) |
For Period |
|
TLSA:NumberOfShareOptionsForfeited |
470 |
Outstanding at 31 December |
Concept (Shares) |
As Of |
|
TLSA:NumberOfShareOptionsOutstanding |
471 |
Exercisable at 31 December |
Concept (Shares) |
As Of |
|
TLSA:NumberOfShareOptionsExercisable |
472 |
00000067 - Disclosure - Share Based Payments (Details Textual) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ShareBasedPaymentsDetailsTextual |
473 |
Implied Table |
Table |
* |
* |
implied:Table |
474 |
Share Based Payments |
Abstract |
|
|
TLSA:DisclosureofShareBasedPaymentsAlbstract |
475 |
Share Based Payments (Textual) |
Abstract |
|
|
TLSA:ShareBasedPaymentsTextualAbstract |
476 |
Fair value of the share option instruments |
Concept (Monetary) |
As Of |
Credit |
TLSA:FairValueshareoptioninstruments |
477 |
Fair value of the warrant instruments |
Concept (Monetary) |
As Of |
Credit |
TLSA:Fairvalueofwarrantinstruments |
478 |
Share-based payment |
Concept (Monetary) |
For Period |
Debit |
TLSA:SharePasedPayment |
479 |
Expected term of the awards |
Concept (xbrli:durationItemType) |
For Period |
|
TLSA:ExpectedTermOfAwards |
480 |
00000068 - Disclosure - Convertible Loan Notes (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ConvertibleLoanNotesDetails |
481 |
Implied Table |
Table |
* |
* |
implied:Table |
482 |
Convertible Loan Notes |
Abstract |
|
|
TLSA:ConvertibleLoanNotesAbstract |
483 |
Convertible loan notes issued |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NotesAndDebenturesIssued |
484 |
Accrued interest |
Concept (Monetary) |
As Of |
Credit |
TLSA:Accruedinterest |
485 |
Planwise Convertible Loan Note |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Borrowings |
486 |
00000069 - Disclosure - Convertible Loan Notes (Details Textual) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ConvertibleLoanNotesDetailsTextual |
487 |
Implied Table |
Table |
* |
* |
implied:Table |
488 |
Convertible Loan Notes |
Abstract |
|
|
TLSA:ConvertibleLoanNotesAbstract |
489 |
Convertible Loan Notes (Textual) |
Abstract |
|
|
TLSA:ConvertibleLoanNotesTextualAbstract |
490 |
Description of convertible loan notes |
Concept (Text/String) |
For Period |
|
TLSA:DescriptionofBorrowings |
491 |
00000070 - Disclosure - Reserves (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/ReservesDetails |
492 |
Implied Table |
Table |
* |
* |
implied:Table |
493 |
Notes to Financial Statements |
Abstract |
|
|
TLSA:NotesToFinancialStatementsAbstract |
494 |
Capital reduction reserve |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ReductionOfIssuedCapital |
495 |
00000072 - Disclosure - Trade and Other Payables (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/TradeAndOtherPayablesDetails |
496 |
Implied Table |
Table |
* |
* |
implied:Table |
497 |
Trade and other payables [abstract] |
Abstract |
|
|
ifrs-full:TradeAndOtherPayablesAbstract |
498 |
Trade payables |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers |
499 |
Accruals |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AccrualsClassifiedAsCurrent |
500 |
Convertible loan note liability |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:OtherCurrentPayables |
501 |
Related party payable |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties |
502 |
Total |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayables |
503 |
00000074 - Disclosure - Operating Leases (Details) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OperatingLeasesDetails |
504 |
OperatingLeasesTable [Table] |
Table |
* |
* |
TLSA:OperatingLeasesTable |
505 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
506 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
507 |
Less than one year [Member] |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
508 |
Between one and five years [Member] |
Member |
|
|
ifrs-full:LaterThanFiveYearsMember |
509 |
OperatingLeasesLineItems [Line Items] |
LineItems |
|
|
TLSA:OperatingLeasesLineItems |
510 |
Future minimum rentals payable under non-cancellable operating leases |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:MinimumFinanceLeasePaymentsPayable |
511 |
00000075 - Disclosure - Operating Leases (Details Textual) |
Network |
* |
* |
http://info@tizianalifesciences.com/role/OperatingLeasesDetailsTextual |
512 |
Implied Table |
Table |
* |
* |
implied:Table |
513 |
Operating Leases |
Abstract |
|
|
TLSA:OperatingLeasesAbstract |
514 |
Operating Leases (Textual) |
Abstract |
|
|
TLSA:OperatingLeasesTextualAbstract |
515 |
Lease expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ContingentRentsRecognisedAsExpenseClassifiedAsOperatingLease |